These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 84209)

  • 141. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
    Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
    J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
    Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
    J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Contemporary trends in conjugate vaccine development.
    Cruse JM; Lewis RE
    Contrib Microbiol Immunol; 1989; 10():1-10. PubMed ID: 2510970
    [No Abstract]   [Full Text] [Related]  

  • 144. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine.
    Mäkelä PH; Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298
    [No Abstract]   [Full Text] [Related]  

  • 146. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 147. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Current status and prospects for some improved and new bacterial vaccines.
    Robbins FC; Robbins JB
    Annu Rev Public Health; 1986; 7():105-25. PubMed ID: 3521639
    [No Abstract]   [Full Text] [Related]  

  • 149. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
    Anderson PW; Stein EC; Insel RA
    Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504
    [No Abstract]   [Full Text] [Related]  

  • 150. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 151. The biology of Haemophilus influenzae type b vaccination failure.
    Holmes SJ; Granoff DM
    J Infect Dis; 1992 Jun; 165 Suppl 1():S121-8. PubMed ID: 1588145
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides.
    Pandey JP; Fudenberg HH; Virella G; Kyong CU; Loadholt CB; Galbraith RM; Gotschlich EC; Parke JC
    Lancet; 1979 Jan; 1(8109):190-2. PubMed ID: 84209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 8.